Molecular Test Systems for Computational Selectivity Studies and Systematic Analysis of Compound Selectivity Profiles

Methods in Molecular Biology

Volumn 672, Issue , 2011, Pages 503-515

  Stumpfe, Dagmar ^a   Lounkine, Eugen ^a   Bajorath, Jürgen ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Chemical biology; Compound selectivity; Formal concept analysis; Molecular formal concept analysis; Selectivity searching; Structure selectivity relationships

Indexed keywords

CHEMICAL GENETICS; CONCEPT ANALYSIS; MINING; MOLECULAR PROBE; ARTICLE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER ANALYSIS; COMPUTER PROGRAM; DATA MINING; ENZYME SPECIFICITY; GENETICS; METHODOLOGY; QUALITY CONTROL; STRUCTURE ACTIVITY RELATION;

BENCHMARKING; COMPUTATIONAL BIOLOGY; COMPUTING METHODOLOGIES; DATA MINING; MOLECULAR PROBES; MOLECULAR STRUCTURE; SOFTWARE DESIGN; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

MLCS; MLOWN;

EID: 79952117971     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-839-3_20     Document Type: Chapter

References (21)

1. Jacoby, E. (2006) Chemogenomics: drug dis-covery’s panacea? Mol. Biosyst. 2, 218–220.
2. Spring, D. R. (2005) Chemical genetics to chemical genomics: small molecules offer big insights. Chem. Soc. Rev. 34, 472–482.
3. Bajorath, J. (2008) Computational approaches in chemogenomics and chemical biology: current and future impact on drug discovery. Expert. Opin. Drug Discov. 3, 1371–1376.
4. Tan, D. S. (2005) Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nat. Chem. Biol 1, 74–84.
5. Stockwell, B. R. (2004) Exploring biology with small organic molecules. Nature 432, 846–854.
6. Bredel, M., and Jacoby, E. (2004) Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat. Rev. Genet. 5, 262–275.
7. Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., and Hopkins, A. L. (2006) Global mapping of pharmacological space. Nat. Biotechnol. 24, 805–815.
8. Yildirim, M. A., Goh, K., Cusick, M. E., Barabási, A., and Vidal, M. (2007) Drug-target network. Nat. Biotechnol. 25, 1119–1126.
9. Cheng, Y., and Prusoff, W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108.
10. Stumpfe, D., Ahmed, H. E. A., Vogt, I., and Bajorath, J. (2007) Methods for computer-aided chemical biology. Part 1: design of a benchmark system for the evaluation of compound selectivity. Chem. Biol. Drug Des. 70, 182–194.
11. Stumpfe, D., Geppert, H., and Bajorath, J. (2008) Methods for computer-aided chemical biology. Part 3: analysis of struc-ture-selectivity relationships through single-or dual-step selectivity searching and Bayesian classification. Chem. Biol. Drug Des. 71, 518–528.
12. Johnson, M. A., and Maggiora, G. M. (1990) Concepts and applications of molecular similarity. Wiley, New York.
13. Kubinyi, H. (1998) Similarity and dissimilarity – a medicinal chemist’s view. Perspect. Drug Discov. Des. 11, 225–252.
14. Peltason, L., and Bajorath, J. (2007) Molecular similarity analysis uncovers heterogeneous structure-activity relationships and variable activity landscapes. Chem. Biol. 14, 489–497.
15. Vogt, I., Stumpfe, D., Ahmed, H. E. A., and Bajorath, J. (2007) Methods for computer-aided chemical biology. Part 2: evaluation of compound selectivity using 2D molecular fingerprints. Chem. Biol. Drug Des. 70, 195–205.
16. Wassermann, A. M., Geppert, H., and Bajorath, J. (2009) Searching for target-selective compounds using different combinations of multiclass support vector machine ranking methods, kernel functions, and fingerprint descriptors. J. Chem. Inf. Model. 49, 582–592.
17. Vogt, I., Ahmed, H. E. A., Auer, J., and Bajorath, J. (2008) Exploring structure-selectivity relationships of biogenic amine GPCR antagonists using similarity searching and dynamic compound mapping. Mol. Divers. 12, 25–40.
18. Priss, U. (2006) Formal concept analysis in information science. Annu. Rev. Inform. Sci. Technol. 40, 521–543.
19. Lounkine, E., Auer, J., and Bajorath, J. (2008) Formal concept analysis for the identification of molecular fragment combinations specific for active and highly potent compounds. J. Med. Chem. 51, 5342–5348.
20. Lounkine, E., Stumpfe, D., and Bajorath, J. (2009) Molecular Formal Concept Analysis for compound selectivity profiling in biologically annotated databases. J. Chem. Inf. Model. 49, 1359–1368.
21. Duvic, M., Talpur, R., Ni, X., Zhang, C., Hazarika, P., Kelly, C., Chiao, J. H., Reilly, J. F., Ricker, J. L., Richon, V. M., and Frankel, S. R. (2007) Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood 109, 31–39.